Article
Role of salt‑inducible kinase 2 in the malignant behavior and glycolysis of colorectal cancer cells
24 Sept 2021
Abstract excerpt
Colorectal cancer (CRC) is the third most common type of cancer worldwide. Currently, surgery, chemotherapy and radiation therapy are the conventional approaches used to treat CRC. However, these therapy strategies cause several side effects. The present study aimed to develop an alternative and more effective treatment approach for patients with CRC. It has been reported that salt‑inducible kinase 2 (SIK2) acts...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
